lactobacillus jensenii
Cell therapyexperimental
Lactobacillus jensenii is a lactic acid bacteria species in the genus Lactobacillus. — Wikipedia
Clinical trial activity
7 trials · 15 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Feb 1, 2015 (NCT02744638)
Timeline
Indications
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaLactobacillus jensenii ↗
Also known as
- lactobacillus jensenii
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07181486 | Phase 1 | Sep 22, 2025 | DF/Net Research, Duke University, National Institute of Allergy and Infectious Diseases (NIAID), Osel, Inc., University of California, San Francisco |
| NCT04373512 | Phase 3 | May 31, 2020 | Georgetown University |
| NCT04246151 | Early Phase 1 (Phase 1) | Mar 31, 2020 | Hamilton Health Sciences Corporation |
| NCT04118049 | N/A | Oct 30, 2019 | University of Connecticut, University of Maryland |
| NCT04025983 | N/A | Jul 31, 2019 | Institute of Gastroenterology and Hepatology, Vietnam |
| NCT03904407 | N/A | Jun 1, 2019 | Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction, University of North Carolina at Chapel Hill |
| NCT02744638 | N/A | Feb 1, 2015 | Dairyfem R&D GmbH, University of Kiel, University of Natural Resources and Life Sciences |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (15)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dairyfem R&D GmbH | For profit | 1 | 0 | 1 | 2015 |
| DF/Net Research | For profit | 1 | 0 | 1 | 2025 |
| Duke University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Georgetown University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Hamilton Health Sciences Corporation | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Institute of Gastroenterology and Hepatology, Vietnam | Academic/Hospital | 1 | 1 | 1 | 2019 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 0 | 1 | 2025 |
| Osel, Inc. | For profit | 1 | 0 | 1 | 2025 |
| Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | 2025 |
| University of Connecticut | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of Kiel | Academic/Hospital | 1 | 1 | 1 | 2015 |
| University of Maryland | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of Natural Resources and Life Sciences | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of North Carolina at Chapel Hill | Academic/Hospital | 1 | 1 | 1 | 2019 |
15 organizations
Page 1 / 1